Olivia M. Jochl

Olivia M. Jochl

Auto-generated profile, based on publicly available information

Olivia M. Jochl

Hospital for Special Surgery, New York, NY, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2025 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Open access
ZTZachary A. Bs Trotzky
Zachary A. Bs Trotzky
RSRyan G. Ba Smolarsky
Ryan G. Ba Smolarsky
SMSophia J. Ba Madjarova
Sophia J. Ba Madjarova
OJOlivia M. Jochl
Olivia M. Jochl
BRBenjamin F. Ricciardi
Benjamin F. Ricciardi
ESErnest L. Sink
Ernest L. Sink
Background: The utility of patient-reported outcome measures (PROMs) has been well established, but their interpretation relies on population-specific definitions of meaningful improvement. As such, the minimum clinically important difference (MCID), substantial clinical benefit (SCB), and patient-acceptable symptom state (PASS) thresholds have become prominent metrics in the orthopaedic evidence to ascribe clinical relevance to numeric PROM scores. Studies assessing outcomes of periacetabular osteotomy (PAO) relative to the MCID and PASS have previously evaluated patients against thresholds defined for hip arthroscopy for the treatment of femoroacetabular impingement or distribution-based MCID calculations. These scores may not accurately reflect the status or expectations of patients with a different symptom profile undergoing open hip preservation surgery. Questions/purposes: For patients treated with PAO, we sought to (1) define the MCID, SCB, and PASS threshold values for the mHHS (modified Harris hip score) and International Hip Outcome Tool 12 (iHOT-12) using anchor-based methods; (2) assess the validity of MCID and SCB estimates against minimal detectable change (MDC) values; and (3) determine the proportion of patients who achieved a clinically meaningful threshold. Methods: Between February 2011 and May 2023, a total of 690 patients underwent PAO for symptomatic acetabular dysplasia at one institution and were included in a longitudinally maintained hip preservation registry. The cohort used to define and validate MCID, SCB, and PASS threshold values consisted of those with a completed postoperative anchor questionnaire, which yielded 456 patients as potentially eligible. An additional 139 patients were excluded because of missing mHHS or iHOT-12 scores during the eligibility window (1 to 2 years postoperatively), leaving 70% (317 of 456) of patients to define and validate MCID, SCB, and PASS at a mean ± SD of 1.0 ± 0.3 years of follow-up. A minimum 1-year follow-up was chosen to reduce recall bias. The cohort for defining MCID, SCB, and PASS (94% [298 of 317] women, mean ± SD age at time of surgery 27 ± 8 years) included 21% (68 of 317) of patients with prior ipsilateral surgery. From those registry patients without complete anchor questionnaires, 37% (137 of 373) were identified with pre- and postoperative PROM scores at a mean ± SD of 1.0 ± 0.9 years of follow-up to form the sample for assessing the proportion of patients achieving a clinically meaningful threshold. The MCID, SCB, and PASS thresholds for the mHHS and iHOT-12 were calculated through an anchor-based approach, using area under the receiver operating curve to determine cut points that best identified positive responses, according to quality of life–based anchor questions. The MDC was calculated with confidence intervals (CIs) reflecting 80%, 90%, and 95% certainty to determine the smallest change in the PROM scores that can be considered above the level of measurement error. The validity of MCID estimates was assessed by confirming that they exceeded corresponding MDC values. The validity of SCB estimates were assessed by confirming that they exceeded corresponding MCID values. The proportion of patients achieving a clinically meaningful threshold was determined by calculating the percentage of patients who met the defined anchor-based scores. Results: The MCID, SCB, and PASS thresholds for the mHHS were 18, 23, and 71, respectively. The MCID, SCB, and PASS thresholds for the iHOT-12 were 26, 42, and 65, respectively. The MDC ranged from 8 to 12 for the mHHS and 10 to 16 for the iHOT-12. The MCID values for the mHHS and iHOT-12 exceeded corresponding values of the MDC at all CIs. The SCB thresholds exceeded all corresponding MDC and MCID values. Across the mHHS and iHOT-12, the proportion of patients who achieved an MCID at the first time point ranged from 60% to 73%, the proportion of patients who achieved the SCB ranged from 49% to 56%, and the proportion of patients who achieved the PASS threshold ranged from 55% to 79%. Among the cohort for defining MCID, SCB, and PASS, the proportion of patients achieving any MCID, SCB, or PASS was 79%, 66%, and 81%, respectively. Among the sample for assessing the proportion of patients achieving a clinically meaningful threshold, the proportion achieving any MCID, SCB, or PASS threshold was 74%, 58%, and 72%, respectively. Conclusion: We found that using a sample of patients undergoing PAO, the anchor-based values for the MCID and SCB were generally larger than previous distribution- and anchor-based scores that have been defined for hip preservation, whereas PASS threshold scores were similar. All MCID and SCB thresholds exceeded corresponding MDC values, confirming these scores to be valid estimates. These metrics provide more rigorous, procedure-specific definitions for the evaluation of treatment success and failure after PAO. As anchor-based metrics are defined based on patients’ perceptions, they should be used preferentially for postoperative assessment over distribution-based scores. Level of Evidence: Level III, therapeutic study.

1 January 2026 in JBJS Open Access
Verified
Journal Article
Open access
ZTZachary A. Trotzky
Zachary A. Trotzky
RLRanqing Lan
Ranqing Lan
OJOlivia M. Jochl
Olivia M. Jochl
PFPatricia Friedmann
Patricia Friedmann
MFMark A. Fontana
Mark A. Fontana
ESErnest L. Sink
Ernest L. Sink
Background: A strong association exists between outcomes of orthopaedic surgery and patients' preoperative mental health. Therefore, population-wide trends and changes in well-being are of great interest to providers. We sought to describe the well-being among patients undergoing orthopaedic surgery before, during, and after the pandemic. Methods: Patients who underwent an orthopaedic surgical procedure at 1 specialty hospital in New York City between 2019 and August 2024 were split into prepandemic, pandemic, and postpandemic groups (n = 129,677). Preoperative Patient-Reported Outcome Measurement Information System Scale v1.2-Global Health (PROMIS-GH) mental health (MH) and physical health (PH) scores were analyzed in addition to the proportion of patients with low MH and PH. Demographic and clinical factors associated with low MH/PH were identified. Results: Median PROMIS MH and PH scores declined in the pandemic cohort and remained decreased in the postpandemic cohort. Compared with the prepandemic cohort, the proportion of patients with low MH increased in the pandemic cohort (11% vs. 5%) and increased further in the postpandemic cohort (14%). Compared with the prepandemic cohort, the proportion of patients with low PH increased in the pandemic cohort (37% vs. 25%) and increased further in the postpandemic cohort (40%). Relative to the prepandemic period, the odds of low MH adjusted for demographic, clinical, and social factors were 2.70 for the pandemic period and 3.46 for the postpandemic period; for low PH 1.95 and 2.21, respectively. Factors associated with low MH/PH included preoperative comorbidities, age, sex, ethnicity, insurance type, socioeconomic status, and surgery within the spine service. Conclusion: Our results suggest that mental and physical health among patients undergoing orthopaedic surgery in New York City worsened during the pandemic. In the postpandemic period, mental and physical health has continued to decline with a higher proportion of low MH and low PH compared with prepandemic and pandemic levels. The persistent decline observed past the pandemic period indicates that long-term social and societal factors may be associated with population-wide changes in psychosocial functioning rather than exclusively pandemic-specific determinants. In response to this negative trend, surgeons and institutions should consider additional preoperative supports for patients with diminished well-being. Level of Evidence: Level III —Retrospective cohort study. See Instructions for Authors for a complete description of levels of evidence.

22 September 2026 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Open access
ZTZachary A. Trotzky
Zachary A. Trotzky
COCassidy E. Owens
Cassidy E. Owens
OJOlivia M. Jochl
Olivia M. Jochl
SMSophie Rosa Merckaert
Sophie Rosa Merckaert
ESErnest L. Sink
Ernest L. Sink
Background: Anchor-based thresholds of the minimum clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) were recently defined for the modified Harris hip score (mHHS) and the International Hip Outcome Tool 12 (iHOT-12) among patients undergoing periacetabular osteotomy (PAO). However, the likelihood of meeting these thresholds and the amount of time it takes for patients to achieve them remain unknown. Understanding the probability of achieving the MCID, SCB, and PASS throughout the postoperative course is important for fair preoperative counseling. Questions/purposes: (1) For patients treated with PAO, what is the probability of achieving the MCID, SCB, and PASS for the mHHS and iHOT-12 at 1, 2, 5, and 10 years postoperatively using threshold values that accurately characterize the perceptions of patients undergoing PAO? (2) Which factors are associated with time to achieving the MCID, SCB, or PASS? Methods: Between March 2011 and February 2025, a total of 784 patients underwent PAO for symptomatic acetabular dysplasia at one institution. Of these, 0.4% (3 of 784) who underwent conversion THA were excluded, yielding 781 patients as potentially eligible. Patients without minimum 1-year postoperative PROMs were also excluded, leaving 85% (665 of 781) of patients for analysis. The study cohort (in which 94% [622 of 665] were women, with a mean ± SD age at time of surgery of 26 ± 8 years) included 24% (158 of 665) of patients with prior ipsilateral hip surgery and 37% (246 of 665) of patients with a psychiatric diagnosis. Cumulative probabilities were determined using a parametric survival model under a Weibull distribution with interval censoring. Outcome changes of the mHHS and iHOT-12 were evaluated against the anchor-based MCID and SCB thresholds from prior work. Postoperative scores were evaluated against PASS thresholds from prior work. Intervals were constructed for each patient, ranging from the last known point at which a threshold was not achieved to the earliest time point at which a threshold was met. Weibull regression models were used to identify variables associated (p < 0.05) with the time to achieving each outcome threshold. Results: For the mHHS, the cumulative probability of achieving the MCID, SCB, and PASS was as follows: 61% at 1 year, 71% at 2 years, 83% at 5 years, and 90% at 10 years for the MCID; 53% at 1 year, 63% at 2 years, 76% at 5 years, and 85% at 10 years for the SCB; and 78% at 1 year, 85% at 2 years, 92% at 5 years, and 96% at 10 years for the PASS. For the iHOT-12, the cumulative probability of achieving the MCID, SCB, and PASS was as follows: 69% at 1 year, 78% at 2 years, 88% at 5 years, and 93% at 10 years for the MCID; 52% at 1 year, 63% at 2 years, 76% at 5 years, and 85% at 10 years for the SCB; and 65% at 1 year, 74% at 2 years, 85% at 5 years, and 91% at 10 years for the PASS. Prior ipsilateral hip surgery was associated with a substantially longer time to reach all thresholds. Having a psychiatric diagnosis was associated with a moderately longer time to reach the MCID, and undergoing bilateral surgery was associated with a substantially longer time to reach the MCID and moderately longer time to reach the SCB. Each 1-point increase in preoperative mHHS and iHOT-12 scores was associated with a slightly longer time to achieve the MCID and SCB and a slightly shorter time to achieve the PASS. Conclusion: We found that at 1 year, the probability of achieving the MCID, SCB, and PASS (61%, 53%, 78% and 69%, 52%, 65% for the mHHS and iHOT-12, respectively) was lower than previously reported rates, indicating that prior research may have minimized the duration of PAO recovery. Thus, patients can be counseled that by 1 year, they may not experience perceptible improvement in their hip pain and function. The probability of achieving all thresholds increased at each subsequent time point, although even at 10 years, 15% of patients were unlikely to consider their improvement to be substantial, and loss to follow-up may cause our estimates of achieving an MCID, SCB, or PASS to be optimistic. Still, the preoperative discussion can also convey that achieving clinically meaningful benefit becomes more likely throughout the postoperative course. Prior ipsilateral surgery, psychological comorbidities, and bilateral surgery were associated with a moderate to substantially longer time to achieve the MCID, SCB, and PASS. These probabilities and factors provide a foundation for setting realistic patient expectations regarding time frames for improvements in pain and function. Level of Evidence: Level III, therapeutic study.